Stock SYMBA SYMBOLLON PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Symbollon Pharmaceuticals Inc. Share Price

Equities

SYMBA

US87151H1068

Biotechnology & Medical Research

Delayed OTC Bulletin Board
Other stock markets
 		5-day change 1st Jan Change
- USD -.--% Intraday chart for Symbollon Pharmaceuticals Inc. -.--% -.--%

Chart Symbollon Pharmaceuticals Inc.

Dynamic Chart

Managers and Directors - Symbollon Pharmaceuticals Inc.

Managers TitleAgeSince
Jack H. Kessler FOU
 Founder 72 01/86/01
Paul C. Desjourdy CEO
 Chief Executive Officer 61 01/93/01
Members of the board TitleAgeSince
Paul C. Desjourdy CEO
 Chief Executive Officer 61 01/93/01
Jack H. Kessler FOU
 Founder 72 01/86/01
Eugene Lieberstein BRD
 Director/Board Member 84 01/98/01
More insiders

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+18.72% 125B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+14.19% 108B
BIONTECH SE Stock BioNTech SE
-4.93% 24.21B
ARGENX SE Stock argenx SE
+3.23% 22.78B
GENMAB A/S Stock Genmab A/S
-10.44% 17.96B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.74% 16.43B
BEIGENE, LTD. Stock BeiGene, Ltd.
-13.31% 16.37B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+2.44% 13.58B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+27.89% 11.66B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. SYMBA Stock